Akanda Corp. (AKAN) Insider Trading Activity

NASDAQ$3.4201-0.12 (-3.39%)
Market Cap
$114,576.00
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
360 of 876
Rank in Industry
16 of 47

AKAN Insider Trading Activity

AKAN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$40,650
1
50
Sells
$10,150
1
50

Related Transactions

HRT FINANCIAL LP10 percent owner
1
$40,650
1
$10,150
$30,501

About Akanda Corp.

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Insider Activity of Akanda Corp.

Over the last 12 months, insiders at Akanda Corp. have bought $40,650 and sold $10,150 worth of Akanda Corp. stock.

On average, over the past 5 years, insiders at Akanda Corp. have bought $40,650 and sold $10,150 worth of stock each year.

Highest buying activity among insiders over the last 12 months: HRT FINANCIAL LP (10 percent owner) — $40,650.

The last purchase of 29,036 shares for transaction amount of $40,650 was made by HRT FINANCIAL LP (10 percent owner) on 2026‑01‑15.

List of Insider Buy and Sell Transactions, Akanda Corp.

2026-01-16SaleHRT FINANCIAL LP10 percent owner
7,868
5.4868%
$1.29
$10,150
-28.21%
2026-01-15PurchaseHRT FINANCIAL LP10 percent owner
29,036
21.304%
$1.40
$40,650
-29.79%
Total: 2
*Gray background shows transactions not older than one year

AKAN Institutional Investors: Active Positions

Increased Positions6+300%18,365+141,269.23%
Decreased Positions<1-50%13-100%
New Positions6New18,365New
Sold Out Positions<1Sold Out13Sold Out
Total Postitions7+250%18,365+141,169.23%

AKAN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.